This activity was developed for nurses, physicians, and other healthcare professionals.
No commerical support was provided for the development of this activity.
STATEMENT OF NEED In spring of 2009, an influenza outbreak appeared in Mexico. Within days of the new strain being recognized, dozens of persons had died, leading to the closure of schools, churches, and other public settings. It quickly spread throughout the world, including the United States and Canada.
On June 11, 2009, the World Health Organization declared a "stage 6 alert," for this outbreak, meaning a global pandemic of novel H1N1 is under way.
Every clinician must understand the signs and symptoms of pandemic influenza, who is at greatest risk of complications and severe illness, how it is treated, who should be tested, and who should be vaccinated. The purpose of this program is to provide clinicians and others an understanding of the H1N1 influenza, its signs and symptoms, risk factors for complications or severe illness, treatments, and tests.
To complete this activity and obtain CNE credit, you must do the following: Read this Course Introduction / Attestation section in its entirety. Read the course material. Complete the Post Test with a score of 80% or more. Submit the online activity evaluation form.
Medcom/Trainex is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation*
Medcom/Trainex is accredited as a provider of continuing nursing education by the California Board of Registered Nursing (provider number CEP 9888), and the Florida Board of Nursing (provider number FBN2818).
*Accreditation refers to recognition of educational activities only and does not imply Commission on Accreditation approval or endorsement of any product.
CREDIT DESIGNATION Medcom, Inc. designates this educational activity for 1 hour of continuing nursing education credit.
This course is designed to provide clinicians and other healthcare providers an understanding of the signs and symptoms of H1N1 influenza, who is at greatest risk of complications and severe illness, how it is treated, who should be tested, and who should be vaccinated. The program describes the pandemic H1N1 influenza, its signs and symptoms, risks, treatments, and tests. The material is organized around the following categories: Introduction Pandemic Influenza Signs and Symptoms Vaccination Testing General Treatment Post-Exposure Chemoprophylaxis and Empiric Treatment With Antivirals Facility and Staff Protection Conclusion
LEARNING OBJECTIVES After completing this course, the learner should be able to: Describe the signs and symptoms of novel H1N1 influenza Describe the risk factors for developing complications or severe illness Name the initial CDC targets for vaccination against novel H1N1 Name the antiviral medications and who should receive them Describe the CDC recommended plan to prepare an outpatient facility for a local outbreak of pandemic influenza
Medcom, Inc. is the corporate author of this educational activity.
In accordance with ANCC Standards, parallel documents from other accrediting bodies, and Medcom, Inc. policy, the learner is hereby informed that the planners and staff of Medcom, Inc., and the content validation reviewer(s) involved with this activity have reported no relevant financial relationships with commercial interests. Furthermore, there is no discussion in this activity about the use of products for non FDA-approved indications.
UNAPPROVED USE DISCLOSURE Medcom, Inc. requires authors and content validation reviewers to disclose to the learner when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Authors of this activity may present information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. As in all educational activities, we encourage the practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account the patient's unique clinical situation. Medcom disclaims any liability and/or loss resulting from the information contained in this activity. The learner specifically agrees to indemnify and hold Medcom, the creators, producers, and distributors of this activity harmless against any and all claims or liabilities arising out of the use of any information provided in this activity by the learner, or by anyone directly or indirectly obtaining such information through the learner.